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1. Introduction 
Tetrahydrobiopterin is synthesized from guanosine 
triphosphate (GTP)in several enzymatic steps [ 1,2]. 
Details of the pathway of the biopterin biosynthesis 
in mammals are still unresolved [3]. In rat and human 
brain the rate-limiting enzyme was GTP cyclohydro- 
lase [2], followed by D-erythro-7,8-dihydroneopterin 
triphosphate synthetase. D-Erythro-7,8-dihydroneo- 
pterin triphosphate was directly converted to 'quino- 
noid' dihydrobiopterin byan enzyme not requiring 
pyridine nucleotides or other cofactors for catalytic 
activity [2]. This is in contrast to other results [1 ] 
demonstrating that the conversion of D-erythro-7,8- 
dihydroneopterin triphosphate o L-erythro-dihydro- 
biopterin required 3 distinct protein fractions. A
Mg2+-dependent enzyme (A2) catalyzed the conver- 
sion of D-erythro-7,8-dihydroneopterin triphosphate 
to an intermediate X of unknown structure proposed 
to be 6(1 ',2'-dioxopropyl)-7,8-dihydropterin which
could be degraded to pterin and pyruvic acid [1]. A 
heat labile and NADPH-dependent enzyme (A1) con- 
verted X to sepiapterin. We reported in [4] that 
3'-hydroxysepiapterin is excreted in small amounts in 
the urine of healthy individuals but it is markedly 
increased in patients with dihydrobiopterin-defi- 
ciency. In connection with our studies of atypical 
phenylketonuria, it was of interest to investigate he 
biopterin biosynthesis in man. These data indicate 
that, indeed, also in human kidney and liver, bio- 
pterin synthesis might proceed via compound X and 
sepiapterin. 
2. Materials and methods 
2.1. Biological material 
Livers and kidneys were from male Wistar strain 
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rats (200-400 g) killed by decapitation. Samples of 
human kidney were kindly supplied by Dr O. 
Schmucki, University Hospital Zurich. The kidney 
was removed from a patient with hypernephroma and 
the unaffected parts destined for enzymatic studies 
were stored at -70°C. Human liver from a victim of a 
traffic accident was kindly supplied by Dr P. Meier, 
University Hospital, Zurich. Escherichia coli (half-log 
phase) was from Merck, Darmstadt. 
2.2. Chemicals 
D-Erythro-5,6,7,8-tetrahydroneopterin triphos- 
phate, D-erythro-5,6,7,8-tetrahydroneopterin, sepia- 
pterin, L-erythro-dihydrobiopterin and biopterin were 
gifts from Dr M. Viscontini and Dr B. Schircks [5,6]. 
3'-Hydroxysepiapterin wassynthesized from D- 
erythro-5,6,7,8-tetrahydroneopterin by air oxidation 
[4]. D-[U)4C] Erythro-7,8-dihydroneopterin riphos- 
phate was synthesized from [UJ4C] GTP with GTP 
cyclohydrolase I from E. coli [7] and was used with- 
out purification. 
2.3. Enzymes and assays 
GTP cyclohydrolase I was partially purified from 
extracts of E. coli [8], a column of Ultrogel AcA 34 
(LKB) was used instead of Sephadex G-200 (Phar- 
macia) [1 ]. 
Fractionation of homogenates of 5 g tissue taken 
from rat liver, kidneys or from human liver and kid- 
neys was according to [1 ]. The fractions A1, A2 and 
B were tested for their ability to convert D-[U-14C]- 
erythro-7,8-dihydroneopterin triphosphate o com- 
pound 'X', sepiapterin and L-erythro-dihydrobio- 
pterin. 
'Compound X' was assayed as pyruvate dinitro- 
phenylhydrazone [ 1 ]. The pyruvate dinitrophenyl- 
hydrazone was extracted with chloroform and 
separated by thin-layer chromatography (TLC) in 
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1-butanol-acetic a id-water (20:1:3, by vol.) on 
silica gel 60 F2s4 (Merck, Darmstadt). The zone was 
isochromatographic with authentic pyruvate dinitro- 
phenylhydrazone was scraped off and eluted with 
ethanol-water (80:20, v/v). Radioactivity of the 
eluates was measured in 10 ml scintillation cocktail 
(Lumagel) in a Packard instrument model 2450 
(counting efficiency was 70%). Reductive cleavage of 
pyruvate dinitrophenylhydrazone to alanine was per- 
formed by catalytic hydrogenation with platinum 
oxide in ethanol at pH 7 [9]. Identification of alanine 
was done by TLC in solvent 1-butanol-acetic a id-  
water (4:1 : 1, by vol.) on silica gel. 
2.4. Assay of sepiapterin and dihydrobiopterin 
In 1 ml 0.05 tool/1 Tris buffer (pH 7.4), 500/lg 
protein from the Ultrogel eluate (by Lowry test) or 
200 ~1 6-fold concentrated eluate (fig.l), 20-200 
nmol D- [U-14C] erythro-7,8-dihydroneopterin tri- 
phosphate, 2.5/~mol NADPH and 0.5/lmol MgSO4 
was incubated for 1 h at 37°C in the dark. The mix- 
ture was separated on a column (16 X 320 ram) of 
Ecteola-Sephadex G-25 where pterins eluted in the 
sequence dihydrobiopterin, sepiapterin, biopterin and 
pterin. The pooled dihydrobiopterin and sepiapterin 
fractions were further purified by high-pressure liquid 
chromatography (HPLC) on LiChrosorb RP-8 (Merck, 
Darmstadt) in 0.05% acetic acid. Each fraction was 
concentrated and dihydrobiopterin was oxidized to 
biopterin with manganese dioxide (10 mg/ml) at 
pH 1-2.  After 15 rain the mixture was centrifuged. 
The supernatant as well as the sepiapterin containing 
(not oxidized) fraction were analyzed by TLC in 
1-butanol-acetic a id-water (20:3:7, by vol.) The 
compounds were eluted from the silica gel with etha- 
nol-3% aqueous ammonia (1:1, v/v). 
Sepiapterin reductase was measured according to 
[1 ]. The reaction product was assayed with HPLC 
and identified as dihydrobiopterin by gas chromatog- 
raphy-mass spectrometry (GC-MS). 
3.Results 
Both labeled sepiapterin and dihydrobiopterin 
were found to be the products of the enzymatic on- 
version of D- [ ~4C] erythro-7,8-dihydro neopterin 
triphosphate. These radioactive products were identi- 
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Fig.1. Elution profile of 2 ml of a 40-65% saturated ammonium sulfate fraction of human kidney on an Ultrogel AcA 34 column 
(16 X 580 mm) in 0.05 mol/l potassium phosphate (pH 6.8). Flow rate 10 ml/h, 3 ml fractions. Enzyme activity was determined 
by incubation of 200 ~16-fold concentrated eluate with D-[U-14C]erythro-7,8-dihydroneopterin triphosphate preparation. The 
arrow refers to fraction 34. 
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Table 1 
Products of  [U-~4C]GTP conversion by human kidney and rat liver in vitro 
August 1981 
Material Ultrogel [U-14C]GTP Product dpm . mg protein -1 . h -l % from GTP 
fraction (dpm X 10 -s) 
Human kidney A, 30 a 7.3 [U-14C] Sepiapterin 367 0.05 
B, 34 a 7.3 [U-14C ] Dihydrobiopterin 1200 0.16 
Human kidney A, 26 b 4.4 [U-l*C]Pyruvate hydrazone 2025 0.46 
from compound X
Rat liver A, 28 b 4.4 3720 0.85 
a Fraction number efers to fig.1 
b Fraction numbers correspond to those from different experiments 
fled by a 3-fold purification through Ecteola- 
Sephadex G-25, HPLC and TLC. The dihydrobio- 
pterin-synthesizing system of human kidney was 
separated into two parts with enzymic activity A and 
B by chromatography on Ultrogel AcA 34 (fig.l). 
Fraction 30 corresponding to A was most active in 
converting D-erythro-7,8-dihydroneopterin triphos- 
phate to sepiapterin, whereas fraction 34 correspond- 
ing to B produced most dihydrobiopterin. B was 
found to be sepiapterin reductase [ 1 ] and A corre- 
sponded to the enzyme complex which converts 
D-erythro-7,8-dihydroneopterin triphosphate o sepia- 
pterin [1 ]. Therefore, the activity profile obtained 
from human kidney qualitatively corresponds to that 
obtained from chicken kidney [1]. The [14C]sepia- 
pterin and [14C]dihydrobiopterin produced by frac- 
tion 30 and 34 as found after HPLC and TLC (table 1) 
indicate a low overall yield of conversion. The radio- 
active profile from TLC indicated the presence of 
[xaC]biopterin but also revealed contamination by 
compounds of low mobility. The TLC profile of 
[14C]sepiapterin was found pure. 
The assay for compound 'X' synthesis in the frac- 
tions from Ultrogel chromatography revealed that it 
was coincident with the maximum of sepiapterin 
producing activity. This was observed both in prepa- 
rations from rat liver and human kidney. After reduc- 
tive cleavage of the pyruvate dinitrophenylhydrazone, 
68% of the radioactivity was recovered as [t4c] ala- 
nine. As the protein which synthesized 'X' is heat- 
stable [1 ], it was further purified by heating to 96°C 
for 1 min; this removed phosphatase activity com- 
pletely. After centrifugation the supernatant con- 
tained only 3 proteins as demonstrated by SDS- 
polyacrylamide g l electrophoresis. 
4. Discussion 
The results indicate that biosynthesis of dihydro- 
biopterin in preparations ofhuman kidney and liver 
proceeds similarly to that found in chicken kidney 
[1 ]. We postulated the following pathway [1,4], 
which consists of enzymes A2, A1 and B (sepiapterin 
reductase) as follows: 
D-Erythro-dihydroneopterin 
triphosphate 
Enzyme A2 
/ 
/ 
, i  
3'-Hydroxysepiapterin 
/ t 
/ 
- 3 Pi 
3'-Hydr oxysepiapterin -~  Compound X J I_ triphosphate 
I / . / Enzyme 
. -~  A1 I 
A ~ 
Pterin + pyruvic acid L-Sepiapterin 
Enzyme 
B 
Dihydrobiopterin 
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In the patients with dihydrobiopterin deficiency 
either A2 (triphosphate elimination step) or A1 is 
defective. This would explain the excessive urinary 
excretion of neopterin and dihydroneopterin [ 10-12] 
and 3'-hydroxysepiapterin [4] as well as the response 
of these patients to L-erythro-tetrahydrobiopterin, 
L-erythro-dihydrobiopterin and even better to L-sepia- 
pterin [ 11 ] by normalization of tile elevated serum 
phenylalanine concentration. 
We envisage the development of assays for mea- 
surement of the enzyme activities A2 and A1 in liver 
biopsies. This is under investigation. 
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